Jonathan Inman

I often find myself knee-deep in biotech industry reports, newsletters, industry journals, news, social media and analysis. Every communication piece and organization takes a slightly different angle on summing up the current state and future viability of our industry, but I find a common thread in each. Considerable Opportunity All parties tend to agree that…